Device Trial Radar · NCT07516184
Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Jun 10, 2026
Primary completion
Jun 11, 2027
Study completion Jun 11, 2027
Sponsor
- Lead sponsor
- AstraZenecaNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 7, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center study to explore the positive predictive value of bronchodilation test with portable oscillometry compared to either BDT or BPT with spirometry in asthma diagnosis and to compare it with bronchodilation with spirometry (the current gold standard). In the study, the target patients' profile is the suspected asthma patient with asthmatic symptoms (wheezing, shortness of breath, chest tightness, and/or cough) and aim to enroll 500 participants from 25 sites across different regions in China.
Conditions
- Suspected Asthma
Interventions
Pulmonary function Test interventionDevice
enrollment 500 suspect asthma patients
Primary outcomes
What the sponsor says the trial is designed to measure.
- To explore the diagnostic value of portable oscillometry in suspected asthma patientsTime frame: day 0~7
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Beijing, China · Recruiting
Research Site
Cangzhou, China · Recruiting
Research Site
Changsha, China · Not yet recruiting
21 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.